CIBC World Markets’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $30.3M | Buy |
+52,330
| New | +$29.6M | 0.15% | 98 |
|
|
2025
Q2 | $19.3M | Buy |
47,502
+1,365
| +3% | +$571K | 0.12% | 140 |
|
|
2025
Q1 | $23M | Sell |
46,137
-48,851
| -51% | -$26.5M | 0.18% | 83 |
|
|
2024
Q4 | $49.4M | Buy |
94,988
+43,169
| +83% | +$23.7M | 0.29% | 60 |
|
|
2024
Q3 | $32.1M | Buy |
51,819
+2,662
| +5% | +$1.58M | 0.23% | 71 |
|
|
2024
Q2 | $27.2M | Sell |
49,157
-70,927
| -59% | -$40.6M | 0.18% | 91 |
|
|
2024
Q1 | $69.8M | Sell |
120,084
-49,635
| -29% | -$27.9M | 0.46% | 36 |
|
|
2023
Q4 | $90.1M | Buy |
169,719
+53,417
| +46% | +$25.9M | 0.49% | 30 |
|
|
2023
Q3 | $58.9M | Sell |
116,302
-8,901
| -7% | -$4.74M | 0.58% | 34 |
|
|
2023
Q2 | $65.3M | Buy |
125,203
+105,370
| +531% | +$56.9M | 0.53% | 37 |
|
|
2023
Q1 | $11.4M | Sell |
19,833
-26,276
| -57% | -$14.8M | 0.19% | 100 |
|
|
2022
Q4 | $25.4M | Buy |
46,109
+40,164
| +676% | +$21.3M | 0.17% | 93 |
|
|
2022
Q3 | $3.02M | Sell |
5,945
-21,383
| -78% | -$12M | 0.04% | 215 |
|
|
2022
Q2 | $14.8M | Sell |
27,328
-73,734
| -73% | -$40.6M | 0.14% | 97 |
|
|
2022
Q1 | $59.7M | Buy |
101,062
+26,747
| +36% | +$15.4M | 0.47% | 43 |
|
|
2021
Q4 | $49.6M | Sell |
74,315
-14,457
| -16% | -$9.03M | 0.26% | 62 |
|
|
2021
Q3 | $50.7M | Buy |
88,772
+39,483
| +80% | +$21.7M | 0.34% | 54 |
|
|
2021
Q2 | $24.9M | Sell |
49,289
-63,255
| -56% | -$29.8M | 0.17% | 91 |
|
|
2021
Q1 | $51.4M | Buy |
112,544
+33,323
| +42% | +$15.9M | 0.32% | 59 |
|
|
2020
Q4 | $36.9M | Buy |
79,221
+31,579
| +66% | +$14.8M | 0.19% | 95 |
|
|
2020
Q3 | $21M | Buy |
47,642
+8,868
| +23% | +$3.66M | 0.2% | 114 |
|
|
2020
Q2 | $14M | Sell |
38,774
-25,853
| -40% | -$8.67M | 0.15% | 134 |
|
|
2020
Q1 | $18.3M | Buy |
64,627
+17,211
| +36% | +$5.43M | 0.23% | 100 |
|
|
2019
Q4 | $15.4M | Sell |
47,416
-96,613
| -67% | -$29.3M | 0.1% | 202 |
|
|
2019
Q3 | $42M | Buy |
144,029
+52,635
| +58% | +$15.1M | 0.39% | 65 |
|
|
2019
Q2 | $26.8M | Sell |
91,394
-4,973
| -5% | -$1.37M | 0.21% | 122 |
|
|
2019
Q1 | $26.4M | Sell |
96,367
-34,200
| -26% | -$8.51M | 0.22% | 107 |
|
|
2018
Q4 | $29.2M | Buy |
130,567
+4,191
| +3% | +$983K | 0.27% | 94 |
|
|
2018
Q3 | $30.8M | Sell |
126,376
-70,536
| -36% | -$16.2M | 0.26% | 99 |
|
|
2018
Q2 | $40.8M | Buy |
196,912
+122,435
| +164% | +$26M | 0.35% | 68 |
|
|
2018
Q1 | $15.4M | Sell |
74,477
-95,632
| -56% | -$20.1M | 0.16% | 133 |
|
|
2017
Q4 | $32.3M | Buy |
170,109
+108,600
| +177% | +$20.8M | 0.23% | 93 |
|
|
2017
Q3 | $11.6M | Buy |
61,509
+6,220
| +11% | +$1.13M | 0.11% | 159 |
|
|
2017
Q2 | $9.65M | Sell |
55,289
-155,487
| -74% | -$26.1M | 0.1% | 198 |
|
|
2017
Q1 | $32.4M | Buy |
210,776
+13,660
| +7% | +$2.09M | 0.26% | 71 |
|
|
2016
Q4 | $27.8M | Buy |
197,116
+126,683
| +180% | +$18.7M | 0.28% | 85 |
|
|
2016
Q3 | $11.2M | Buy |
+70,433
| New | +$10.9M | 0.21% | 110 |
|
Other funds holding TMO
JSC
CIBC World Markets's TMO Position: Q4 2025 in Review
CIBC World Markets opened a new position in Thermo Fisher Scientific (TMO) in Q4 2025: 52,330 shares worth $30.3M. The stake represents 0.15% of the portfolio and ranks #98 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in TMO as recently as Q2 2025.
CIBC World Markets first reported a position in TMO in Q3 2016 and has held it in 37 quarters since. The position peaked at $90.1M in Q4 2023. 2,699 funds tracked by Wall St. Rank hold TMO as of Q4 2025.
- CIBC World Markets held 52,330 shares of Thermo Fisher Scientific worth $30.3M as of Q4 2025.
- Thermo Fisher Scientific was a new CIBC World Markets position in Q4 2025.
- Thermo Fisher Scientific made up 0.15% of CIBC World Markets's portfolio in Q4 2025, its #98 holding.
- CIBC World Markets first reported a position in Thermo Fisher Scientific in Q3 2016 and has held it in 37 quarters since.
- CIBC World Markets's Thermo Fisher Scientific position peaked at $90.1M in Q4 2023.
- 2,699 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.
Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.